is a natural collagen vascular graft. Its biological
fibrous matrix is processed to enhance long term patency and
provide a tightly woven, cross-linked conduit that is flexible and compliant.

was the first vascular graft approved by the FDA (1970) and has been in continuous clinical use ever since.

is approved for use, distal to the aorta, for segmental bypass, arterial replacement, patch graft, and femoropopliteal bypass when the patient’s saphenous is absent or inadequate, but is predominantly used as a hemodialysis graft.

is a Class III, life-sustaining implantable device.